Point72 Asset Management
GRCL

Point72 Asset Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Point72 Asset Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,200
Closed -$89.9K – 2250
2023
Q3 		$89.9K Sell
31,200
-968,800
-97% -$2.79M ﹤0.01% 1326
2023
Q2 		$3.81M Buy
+1,000,000
New +$3.81M 0.01% 725